Effect of Oxycodone-Based Multimodal Analgesia on Visceral Pain After Major Laparoscopic Gastrointestinal Surgery: A Randomised, Double-Blind, Controlled Trial
Guo-Wang Yang,Hao Cheng,Xiao-Yang Song,Yu-Fan Yang,Hong Liu,Fu-Hai Ji,Ke Peng
DOI: https://doi.org/10.2147/dddt.s464518
IF: 4.3188
2024-05-28
Drug Design Development and Therapy
Abstract:Guo-Wang Yang, 1, 2 Hao Cheng, 1, 2 Xiao-Yang Song, 3 Yu-Fan Yang, 1, 2 Hong Liu, 4 Fu-Hai Ji, 1, 2 Ke Peng 1, 2 1 Department of Anaesthesiology, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, People's Republic of China; 2 Institute of Anaesthesiology, Soochow University, Suzhou, Jiangsu, People's Republic of China; 3 Department of Anaesthesiology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, Jiangsu, People's Republic of China; 4 Department of Anaesthesiology and Pain Medicine, University of California Davis Health, Sacramento, CA, USA Correspondence: Ke Peng, Department of Anaesthesiology, the First Affiliated Hospital of Soochow University, 188 Shizi St, Suzhou, Jiangsu, 215006, People's Republic of China, Tel +86-15962155989, Email Purpose: Oxycodone is a potent μ- and κ-opioid receptor agonist that can relieve both somatic and visceral pain. We assessed oxycodone- vs sufentanil-based multimodal analgesia on postoperative pain following major laparoscopic gastrointestinal surgery. Methods: In this randomised double-blind controlled trial, 40 adult patients were randomised (1:1, stratified by type of surgery) to receive oxycodone- or sufentanil-based multimodal analgesia, comprising bilateral transverse abdominis plane blocks, intraoperative dexmedetomidine infusion, flurbiprofen axetil, and oxycodone- or sufentanil-based patient-controlled analgesia. The co-primary outcomes were time-weighted average (TWA) of visceral pain (defined as intra-abdominal deep and dull pain) at rest and on coughing during 0– 24 h postoperatively, assessed using the numerical rating scale (0– 10) with a minimal clinically important difference of 1. Results: All patients completed the study (median age, 64 years; 65% male) and had adequate postoperative pain control. The mean (SD) 24-h TWA of visceral pain at rest was 1.40 (0.77) in the oxycodone group vs 2.00 (0.98) in the sufentanil group (mean difference=− 0.60, 95% CI, − 1.16 to − 0.03; P =0.039). Patients in the oxycodone group had a significantly lower 24-h TWA of visceral pain on coughing (2.00 [0.83] vs 2.98 [1.26]; mean difference=− 0.98, 95% CI, − 1.66 to − 0.30; P =0.006). In the subgroup analyses, the treatment effect of oxycodone vs sufentanil on the co-primary outcomes did not differ in terms of age (18– 65 years or > 65 years), sex (female or male), or type of surgery (colorectal or gastric). Secondary outcomes (24-h TWA of incisional and shoulder pain, postoperative analgesic usage, rescue analgesia, adverse events, and patient satisfaction) were comparable between groups. Conclusion: For patients undergoing major laparoscopic gastrointestinal surgery, oxycodone-based multimodal analgesia reduced postoperative visceral pain in a statistically significant but not clinically important manner. Trial Registration: Chinese Clinical Trial Registry (ChiCTR2100052085). Keywords: laparoscopic gastrointestinal surgery, oxycodone, patient-controlled analgesia, visceral pain Laparoscopic gastrointestinal surgery is a widely performed procedure, with comparable safety and long-term outcomes to conventional open laparotomy. 1–3 Patients undergoing major laparoscopic gastrointestinal surgery often experience moderate to severe postoperative pain, especially visceral pain. Visceral pain is deep and dull pain inside the abdomen, which cannot be accurately localized. The pathological mechanisms of visceral pain are very complex, involving surgical manipulations, peritoneal inflammation, visceral ischemia, and visceral hypersensitivity due to peripheral and central pathway sensitization. 4 Visceral pain can trigger autonomic nerve reflexes, such as nausea, vomiting, sweating, and cardiovascular and respiratory changes, 5,6 and may provoke negative emotional responses. 7 Early postoperative visceral pain is also related to chronic pain following surgery. 8 Opioids are the cornerstones of postoperative analgesia but are associated with adverse effects. Multimodal analgesic strategy with opioids, non-opioid analgesics, and local anaesthetics has been used to enhance analgesia and reduce opioid-related adverse events. 9–11 Oxycodone, a semisynthetic μ- and κ-opioid receptor agonist may provide a better treatment for both somatic and visceral pain after laparoscopic surgery than other opioids (morphine, fentanyl, sufentanil, or alfentanil). 12–14 Oxycodone has been shown to be effective for postoperative pain control and well-tolerated across a variety of surg -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal